Active Needle Technology has developed technology designed to help doctors perform needle-based procedures with greater accuracy and reliability.

Active Needle completed its SyndicateRoom round in March 2017, overfunding to £350,051.

The story

Using technology licensed from Lightpoint Medical, Active Needle is developing a needle-like device which broadcasts an ultrasound image to help doctors ensure they are sampling the target tissue during biopsies, which are commonly used to diagnose cancers, diseases and infections.

The device itself is designed to be intuitive to use, and aims to provide users with real-time imagery of the procedure, without the need for any specific new software. Rather, it is designed to transmit the signal from the needle to any standard ultrasound probe – a standard piece of hospital equipment.

product1.png

Active Needle Technology believes the device has the potential to significantly reduce inaccuracies, the risk of repeat biopsy and time taken on the procedure, saving millions annually in costs for health services, while increasing hospital capacity and reducing patient anxiety.

The company plans to use funds raised in this round to progress the device to pre-production standard, testing and into regulatory approval.

Ian Quirk, CEO and Co-founder of Active Needle, trained initially as a chemist and began working in product development before gaining expertise at a senior management level in regulatory affairs. As a member of the Institute of Directors and Institute of Clinical Research, Ian has over ten years’ senior management experience in medtech companies and has worked in various markets including orthopaedic, vascular and coronary, paediatric cardiology, ocular, imaging and in-vitro diagnostics.

The lead investor

Lead investor Oxford Technology Management (OTM) has invested £65,000 into Active Needle Technology. Founded in 1983, Oxford Technology Management specialises in making and managing investments in startup and early-stage technology-based businesses with high-growth prospects.

The OTM investment team is made up entirely of scientists and engineers, while its portfolio features unlisted, UK-based technology businesses. In their latest portfolio, Oxford Technology has made 21 investments to date over the last three years.

Lead on this project was Andrea Mica, who has been working in startups and startup investing since 1999.

[The Active Needle team] could understand the technology and its use, and like many others (clinicians) who saw it, said “I can’t believe that hasn’t been invented before” or “I wish I had invented that”.

Andrea Mica

Oxford Technologies

See current opportunities

Alert Technology

EIS
Engineering & Manufacturing
Alert Technology has created a device capable of detecting and monitoring airborne asbestos fibres in real-time. DPTI is a £5m equity funding scheme, managed by NCL, to help cutting-edge science and technology firms to get their products to market.

Active

Trading status

£23,390

Average investment

£1,000,395

Total raised

Boudica Indigo

SEIS
Media & Telecommunications
Boudica Indigo raised £400,000 finance in May 2017 for the film Kat in the Band. Read more about the SEIS opportunity here.

Active

Trading status

£10,000

Average investment

£400,000

Total raised

ThoughtRiver Limited

EIS
Legaltech & Regtech
A SaaS platform that uses artificial intelligence to help companies evaluate the risks of legal contracts. Lead investor Duncan Painter, CEO of Ascential, founded and sold ClarityBlue for £85m.

Active

Trading status

£30,435

Average investment

£700,000

Total raised

Adoreboard Limited

EIS
Software & Computer Services
Adoreboard’s proprietary software allows companies to turn customer emotions into actionable insights. Lead investor, Michael Black, MBE, is currently serving as Chairman and Non-Executive Director for a number of companies, including Adoreboard.

Active

Trading status

£9,703

Average investment

£261,985

Total raised

Squirrel Financial Wellbeing

EIS
Financial Services
Squirrel aims to make it easy and intuitive to create – and stick to – a budget. Find out about Squirrel's funding round and lead investor Jos Evans here.

Active

Trading status

£6,852

Average investment

£465,929

Total raised

Orthogem

EIS
Medtech
Orthogem is focused on the discovery and development of advanced synthetic bone graft. Find out more about Orthogem's raise here.

Active

Trading status

£10,112

Average investment

£566,284

Total raised